Eva A. Ebbing

477 total citations
11 papers, 337 citations indexed

About

Eva A. Ebbing is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eva A. Ebbing has authored 11 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eva A. Ebbing's work include Esophageal Cancer Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Cells and Metastasis (4 papers). Eva A. Ebbing is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Gastric Cancer Management and Outcomes (5 papers) and Cancer Cells and Metastasis (4 papers). Eva A. Ebbing collaborates with scholars based in Netherlands, Australia and Egypt. Eva A. Ebbing's co-authors include Kausilia K. Krishnadath, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma, Jan Paul Medema, Sybren L. Meijer, Mark I. van Berge Henegouwen, Anne Steins, Aafke Creemers, Maarten C.C.M. Hulshof and Cynthia Waasdorp and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and Scientific Reports.

In The Last Decade

Eva A. Ebbing

11 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva A. Ebbing Netherlands 9 233 105 102 90 73 11 337
Elena García-García Spain 7 337 1.4× 68 0.6× 121 1.2× 117 1.3× 100 1.4× 13 431
Marvin Schober Germany 6 242 1.0× 73 0.7× 92 0.9× 48 0.5× 99 1.4× 8 321
Aafke Creemers Netherlands 11 215 0.9× 125 1.2× 77 0.8× 140 1.6× 121 1.7× 16 353
Rafael Álvarez Spain 8 414 1.8× 118 1.1× 62 0.6× 140 1.6× 167 2.3× 15 473
Prabhu Arumugam United Kingdom 9 292 1.3× 87 0.8× 132 1.3× 49 0.5× 99 1.4× 11 386
Gerald Gantt United States 8 335 1.4× 153 1.5× 156 1.5× 71 0.8× 159 2.2× 23 498
Keren Jia China 11 299 1.3× 87 0.8× 124 1.2× 193 2.1× 99 1.4× 20 523
Adam G. Baseman United States 7 129 0.6× 105 1.0× 163 1.6× 149 1.7× 74 1.0× 8 423
Marion Hädrich Switzerland 9 338 1.5× 98 0.9× 86 0.8× 84 0.9× 65 0.9× 12 449

Countries citing papers authored by Eva A. Ebbing

Since Specialization
Citations

This map shows the geographic impact of Eva A. Ebbing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva A. Ebbing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva A. Ebbing more than expected).

Fields of papers citing papers by Eva A. Ebbing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva A. Ebbing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva A. Ebbing. The network helps show where Eva A. Ebbing may publish in the future.

Co-authorship network of co-authors of Eva A. Ebbing

This figure shows the co-authorship network connecting the top 25 collaborators of Eva A. Ebbing. A scholar is included among the top collaborators of Eva A. Ebbing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva A. Ebbing. Eva A. Ebbing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Creemers, Aafke, Anja van de Stolpe, Laurent Holtzer, et al.. (2022). FOXO transcriptional activity is associated with response to chemoradiation in EAC. Journal of Translational Medicine. 20(1). 183–183. 1 indexed citations
2.
Steins, Anne, Remy Klaassen, Igor Jacobs, et al.. (2019). Rapid stromal remodeling by short‐term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma. Molecular Oncology. 14(4). 704–720. 9 indexed citations
3.
Ebbing, Eva A., Anne Steins, Aafke Creemers, et al.. (2019). Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma. Proceedings of the National Academy of Sciences. 116(6). 2237–2242. 129 indexed citations
4.
Steins, Anne, Eva A. Ebbing, Aafke Creemers, et al.. (2019). Chemoradiation induces epithelial‐to‐mesenchymal transition in esophageal adenocarcinoma. International Journal of Cancer. 145(10). 2792–2803. 23 indexed citations
5.
Creemers, Aafke, Eva A. Ebbing, Thomas Pelgrim, et al.. (2018). A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas. Scientific Reports. 8(1). 13281–13281. 25 indexed citations
6.
Creemers, Aafke, Eva A. Ebbing, Gerrit K. Hooijer, et al.. (2018). The dynamics of HER2 status in esophageal adenocarcinoma. Oncotarget. 9(42). 26787–26799. 19 indexed citations
8.
Steins, Anne, Eva A. Ebbing, Cynthia Waasdorp, et al.. (2017). Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel. Drug Delivery. 24(1). 1801–1810. 6 indexed citations
9.
Ebbing, Eva A., Jan Paul Medema, Helene Damhofer, et al.. (2016). ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3. Oncotarget. 7(9). 10243–10254. 30 indexed citations
10.
Damhofer, Helene, Eva A. Ebbing, Anne Steins, et al.. (2015). Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tract. Journal of Translational Medicine. 13(1). 115–115. 54 indexed citations
11.
Ebbing, Eva A., et al.. (2014). Radiosensitization by Thymidine Phosphorylase Inhibitor in Thymidine Phosphorylase Negative and Overexpressing Bladder Cancer Cell Lines. Nucleosides Nucleotides & Nucleic Acids. 33(4-6). 413–421. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026